Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia

Neurosci Res. 2011 Nov;71(3):289-93. doi: 10.1016/j.neures.2011.07.1818. Epub 2011 Jul 27.

Abstract

Schizophrenia (SZ) is a psychiatric disease with plausible neurodevelopmental etiology. Although genetic studies show significant association of immune molecules loci such as major histocompatibility complex (MHC) class I with SZ, it is not clear whether these immune molecules are involved in the pathology observed in SZ brains. MHC class I and the classical pathway components of complement system (C1q and C3) have been shown to regulate brain neuronal maturation and function. We have examined the expression of MHC class I and complement protein C3 in two frontal cortical regions of postmortem brains of SZ patients. Since cigarette smoking may modulate MHC class I protein expression and a higher rate of smoking is observed in SZ patients, we studied the expression of MHC class I and C3 in relation to the presence of smoking. We found that MHC class I protein expression is reduced in the dorsolateral prefrontal cortex (DLPFC) but not in the orbitofrontal cortex (OFC) of nonsmoker SZ patients. We did not observe SZ-associated changes in C3 mRNA expression. Our exploratory research suggests a potential involvement of MHC class I in SZ and implies that smoking might modulate its expression.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement C1q / biosynthesis
  • Complement C1q / genetics
  • Complement C1q / physiology
  • Complement C3 / biosynthesis
  • Complement C3 / genetics
  • Complement C3 / physiology
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology
  • Histocompatibility Antigens Class I / biosynthesis*
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Nicotine / pharmacology
  • Nicotinic Agonists / pharmacology
  • Prefrontal Cortex / immunology
  • Prefrontal Cortex / metabolism*
  • Prefrontal Cortex / pathology
  • Schizophrenia / immunology
  • Schizophrenia / metabolism*
  • Schizophrenia / pathology
  • Smoking / immunology
  • Smoking / metabolism*

Substances

  • Complement C3
  • Histocompatibility Antigens Class I
  • Nicotinic Agonists
  • Nicotine
  • Complement C1q